Delivery Order SPE2DB22D2103-SPE2DB25FR9DY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TIVICAY 50 mg tablets (30-count units) valued at $5,448.89 under a firm fixed-price contract type. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tivicay 50 mg tablets (30-count package) with a ceiling value of $1,334.31. This firm fixed price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.31 to AmerisourceBergen Drug Corp for TIVICAY 50 mg tablets (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,002.93 by the Defense Logistics Agency on August 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of TIVICAY 50 mg tablets (30-count units) with a ceiling value of $11,654.05. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical products to support federal medical procurement needs. The award is performed out of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $20,950.35 to AmerisourceBergen Drug Corp for 30-count bottles of Tivicay 50 mg tablets. This competitive award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $25,752.16 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for September 24, 2025, and fulfillment occurring at the vendor's headquarters in Conshohocken, Pennsylvania. Tivicay is an antiretroviral medication used in the treatment of HIV infection, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $4,002.93 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tivicay 50 mg tablets (30-count packages). The contract is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order represents a task order...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9DYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of TIVICAY 50 mg tablets (30-count units) with a ceiling value of $69,886.40. This firm fixed-price delivery order, with an ultimate completion date of April 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TIVICAY is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection, reflecting the pharmaceutical distributor's critical role in supplying specialized medications to support military and federal healthcare systems. AmerisourceBergen, headquartered in Pennsylvania and registered in the System for Award Management, maintains a comprehensive portfolio of federal medical contracts encompassing brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's ongoing capacity to fulfill federal pharmaceutical procurement requirements through the DLA's global pharmaceutical support program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.9k | 4/23/25 |